Skip to content
10-Q

Quarterly Report

Ocera Therapeutics, Inc.

0001193125-17-342745

← back to feed
Filed
Nov 14, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Oct 31, 2017 26.51M sh
Capex Q3 2017 · Sep 30, 2017 $0
Capex Q3 2017 · Sep 30, 2016 $3K
Operating Cash Flow Q3 2017 · Sep 30, 2017 −$16.16M
Operating Cash Flow Q3 2017 · Sep 30, 2016 −$16.86M
Cash And Equivalents Q3 2017 · Sep 30, 2017 $14.35M
Cash And Equivalents Q3 2017 · Dec 31, 2016 $24.61M
Cash And Equivalents Q3 2017 · Sep 30, 2016 $29.22M
Cash And Equivalents Q3 2017 · Dec 31, 2015 $35.92M
Stockholders Equity Q3 2017 · Sep 30, 2017 $3.85M
Stockholders Equity Q3 2017 · Dec 31, 2016 $15.74M
Current Liabilities Q3 2017 · Sep 30, 2017 $11.74M
Current Liabilities Q3 2017 · Dec 31, 2016 $13.76M
Total Liabilities Q3 2017 · Sep 30, 2017 $11.74M
Total Liabilities Q3 2017 · Dec 31, 2016 $13.9M
Current Assets Q3 2017 · Sep 30, 2017 $14.96M
Current Assets Q3 2017 · Dec 31, 2016 $28.94M
Total Assets Q3 2017 · Sep 30, 2017 $15.59M
Total Assets Q3 2017 · Dec 31, 2016 $29.64M
Sga Expense Q3 2017 · Sep 30, 2017 $2.3M
Sga Expense Q3 2017 · Sep 30, 2017 $7.33M
Sga Expense Q3 2017 · Sep 30, 2016 $2.62M
Sga Expense Q3 2017 · Sep 30, 2016 $8.14M
Rd Expense Q3 2017 · Sep 30, 2017 $3.78M
Rd Expense Q3 2017 · Sep 30, 2017 $11.09M
Rd Expense Q3 2017 · Sep 30, 2016 $4.28M
Rd Expense Q3 2017 · Sep 30, 2016 $12.94M
Net Income Q3 2017 · Sep 30, 2017 −$6.27M
Net Income Q3 2017 · Sep 30, 2017 −$19.09M
Net Income Q3 2017 · Sep 30, 2016 −$7.13M
Net Income Q3 2017 · Sep 30, 2016 −$21.74M